Structural prediction of chimeric immunogen candidates to elicit targeted antibodies against betacoronaviruses.

Publication date: Feb 05, 2025

Betacoronaviruses pose an ongoing pandemic threat. Antigenic evolution of the SARS-CoV-2 virus has shown that much of the spontaneous antibody response is narrowly focused rather than broadly neutralizing against even SARS-CoV-2 variants, let alone future threats. One way to overcome this is by focusing the antibody response against better-conserved regions of the viral spike protein. This has been demonstrated empirically in prior work, but we posit that systematic design tools will further potentiate antigenic focusing approaches. Here, we present a design approach to predict stable chimeras between SARS-CoV-2 and other coronaviruses, creating synthetic spike proteins that display a desired conserved region, in this case S2, and vary other regions. We leverage AlphaFold to predict chimeric structures and create a new metric for scoring chimera stability based on AlphaFold outputs. We evaluated 114 candidate spike chimeras using this approach. Top chimeras were further evaluated using molecular dynamics simulation as an intermediate validation technique, showing good stability compared to low-scoring controls. Experimental testing of five predicted-stable and two predicted-unstable chimeras confirmed 5/7 predictions, with one intermediate result. This demonstrates the feasibility of the underlying approach, which can be used to design custom immunogens to focus the immune response against a desired viral glycoprotein epitope.

Open Access PDF

Concepts Keywords
Betacoronaviruses Antibodies
Molecular Antibody
Pandemic Antigenic
Stable Betacoronaviruses
Viral Chimeras
Chimeric
Conserved
Cov
Design
Focusing
Predict
Regions
Sars
Spike
Viral

Semantics

Type Source Name
drug DRUGBANK Tropicamide
disease IDO protein
disease IDO immune response
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Covid 19
disease IDO host
disease MESH infection
disease MESH influenza
disease MESH point mutations
disease IDO process
drug DRUGBANK Rasagiline
drug DRUGBANK Biotin
pathway REACTOME Budding
drug DRUGBANK Spinosad
disease IDO algorithm

Original Article

(Visited 3 times, 1 visits today)